143 related articles for article (PubMed ID: 4364538)
41. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
[TBL] [Abstract][Full Text] [Related]
42. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
Hewetson JF; Gothoskar B; Klein G
J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
[No Abstract] [Full Text] [Related]
43. Outbreak of Burkitt's-like lymphoma in homosexual men.
Ziegler JL; Drew WL; Miner RC; Mintz L; Rosenbaum E; Gershow J; Lennette ET; Greenspan J; Shillitoe E; Beckstead J; Casavant C; Yamamoto K
Lancet; 1982 Sep; 2(8299):631-3. PubMed ID: 6125777
[TBL] [Abstract][Full Text] [Related]
44. Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).
de Schryver A; Klein G; Hewetson J; Rocchi G; Henle W; Henle G; Moss DJ; Pope JH
Int J Cancer; 1974 Mar; 13(3):353-62. PubMed ID: 4362610
[No Abstract] [Full Text] [Related]
45. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
46. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
47. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
48. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
[TBL] [Abstract][Full Text] [Related]
49. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma.
Kaschka WP; Klein G; Hilgers R; Skvaril F
Clin Exp Immunol; 1984 Jan; 55(1):14-22. PubMed ID: 6319056
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus-associated Burkitt's lymphoma in India.
Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
[TBL] [Abstract][Full Text] [Related]
51. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
52. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
Rocchi G; Hewetson J; Henle W; Henle G
J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
[No Abstract] [Full Text] [Related]
53. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
54. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
[TBL] [Abstract][Full Text] [Related]
55. Historical background; Burkitt's lymphoma and Epstein-Barr virus.
Epstein MA
IARC Sci Publ; 1985; (60):17-27. PubMed ID: 2998988
[No Abstract] [Full Text] [Related]
56. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
57. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
58. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
Levine PH; Ho JH; Nkrumah F; Andrese AP
IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
[No Abstract] [Full Text] [Related]
60. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
Hilgers F; Rosén A; Lamon E; Klein G
J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
